Issue 69, 2016, Issue in Progress

Evidence for a multivalent effect in inhibition of sulfatases involved in lysosomal storage disorders (LSDs)

Abstract

Two newly synthesized nonavalent polyhydroxylated pyrrolidine iminosugars are the first examples of multivalent inhibitors of GALNS and IDS lysosomal enzymes, whose deficiency leads to Morquio A syndrome and Hunter disease, respectively, and pave the way to a pharmacological chaperone or stabilizing enzyme therapy for these LSDs.

Graphical abstract: Evidence for a multivalent effect in inhibition of sulfatases involved in lysosomal storage disorders (LSDs)

Supplementary files

Article information

Article type
Communication
Submitted
17 Jun 2016
Accepted
29 Jun 2016
First published
01 Jul 2016

RSC Adv., 2016,6, 64847-64851

Evidence for a multivalent effect in inhibition of sulfatases involved in lysosomal storage disorders (LSDs)

G. D'Adamio, C. Matassini, C. Parmeggiani, S. Catarzi, A. Morrone, A. Goti, P. Paoli and F. Cardona, RSC Adv., 2016, 6, 64847 DOI: 10.1039/C6RA15806D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements